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INTRODUCTION
A distinctive feature of stem cells (SCs) is their dual capacity for self-renewal and multipotent differentiation. Recent evidence has revealed that in addition to growth factors and the extracellular matrix, various metabolic pathways contribute to the balance between selfrenewal and differentiation of SCs. Indeed, while defined metabolic states are associated with stemness, a switch in metabolic pathways supports divergent cell fate through coordination with signaling and genetic/epigenetic regulation (Folmes et al., 2012b; Shyh-Chang et al., 2013a; Zhang et al., 2012) . In the developing brain, a tight balance between self-renewal and differentiation of neural stem cells (NSC) is important to ensure that correct numbers of neural cells are generated (Götz et al., 2016; Urbán and Guillemot, 2014) . While several studies have highlighted an important role for glycolysis, lipogenesis and mitochondrial activity in neurogenesis (Knobloch and Jessberger, 2017) , the one-carbon (1C) pathway has comparatively received less attention.
1C metabolism is a universal metabolic pathway that couples purine synthesis (required for DNA replication and cell proliferation) and reactive methyl carrier S-adenosylmethionine (SAM) synthesis which is required for methylation reactions and epigenetic modifications. It is fueled by nutrients present in the serum and in the cerebrospinal fluid and it requires folate as an essential co-factor (Ducker and Rabinowitz, 2017) . Folate is best known as a vitamin that prevents neural tube defects during fetal development (Schorah et al., 1980) , and whose deficiency contributes to severe neurodevelopmental and neurological disorders such as epilepsy, microcephaly and intellectual disability (Serrano et al., 2012) , as well as neurodegenerative diseases such as dementia and Alzheimer's disease (Malouf et al., 2003; Ramos et al., 2005) .
Previous studies have highlighted the role of folate in NSC self-renewal and differentiation. For instance, folate deficiency inhibits the proliferation of adult hippocampal NSC in vivo and induces NSC apoptosis in vitro (Kruman et al., 2005; Zhang et al., 2008) . Conversely, NSC respond to folate with increased proliferation and neuronal differentiation (Liu et al., 2013; Luo et al., 2013) . These reports point out the role of 1C metabolism in NSC regulation, however, whether and how it interacts with other regulatory mechanisms that control neurogenesis remain unknown.
Here, we report a link between the Eph:ephrin cell-cell communication pathway and 1C metabolism. Eph receptors, the largest family of receptor tyrosine kinases and their ligands, the ephrins, enable contact-mediated signaling and participate in a wide spectrum of developmental processes through control of cell migration, adhesion and repulsion. While the role of Eph:ephrin signaling in both embryonic and adults neurogenesis is well documented in vivo (Laussu et al., 2014) , its biological outcome is divergent in different contexts (Ashton et al., 2012; Liu et al., 2017; Ottone et al., 2014) . In addition, even though downstream effectors of Eph receptors, such as small GTPases, cytoplasmic kinases and phosphatases are well studied in the context of tissue morphogenesis or axon guidance (Kania and Klein, 2016) , the molecular mechanisms underlying their effect in neurogenesis remain poorly understood.
To gain further insights, we used in vitro and in vivo analyses of embryonic NSC to identify the molecular mechanisms regulating proliferation, self-renewal and differentiation downstream of Eph. We show that ephrin stimulation impaired NSC self-renewal under SC culture conditions and in the developing neocortex. This impairment was associated with increased differentiation but not reduced proliferation rate. Combination of transcriptional and enzymatic analyses revealed a link between Eph-B signaling and 1C folate pathway. This link was further confirmed in vivo. We present evidence that Eph-B forward signaling through alterations in 1C metabolism modifies H3K4 methylation on key progenitor genes. Finally, we
show that these epigenetic changes are inherited and maintained in the long term, thus locking NSC into a differentiation ready state.
RESULTS
Eph-B forward signaling regulates DHFR
To identify the downstream effectors of Eph-B forward signaling, we performed transcriptional analyses of NSC after 2 and 6 hours (h) stimulation with ephrin-B1 recombinant proteins (eB1-Fc) which led to transient phosphorylation of Eph-B receptors ( Figure S1A ). About 400 genes were differentially expressed upon Eph-B activation ( Figure S1B and C) and gene ontology annotation revealed enrichment in genes involved in regulation of gene expression, cellular component organization, metabolic and cellular processes ( Figure 1A ). Upon closer inspection, we identified several genes from the 1C folate pathway whose expression was decreased ( Figure   S1D ) suggesting that this pathway may be downstream of Eph-B signaling. Some of these target genes were validated by qRT-PCR and among them, Dhfr (Dihydrofolate Reductase, DHFR) was consistently and significantly downregulated following eB1-Fc treatment ( Figure 1B ). This decrease in DHFR mRNA at 6h correlated with a detectable and significant decrease of DHFR protein levels 72h post-eB1-Fc treatment ( Figure 1C ). DHFR is a key enzyme in the 1C metabolic pathway that catalyzes the reduction of 7,8-dihydrofolate (DHF) to 5,6,7,8-tetrahydrofolate (THF) and whose activity is inhibited by Methotrexate (MTX), an anti-folate compound (Goldin et al., 1955) . To evaluate the impact of Eph signaling on DHFR activity, we measured DHFR activity in NSC following eB1-Fc treatment and compared it to MTX treatment.
Interestingly, eB1-Fc treatment inhibited DHFR activity in NSC as efficiently as MTX, but with slower kinetics ( Figure 1D ). The delay in DHFR inhibition following eB1-Fc treatment and the sequential decrease of Dhfr mRNA preceding its simultaneous protein and activity reduction indicates that activation of Eph-B forward signaling inhibits DHFR activity by regulation of its expression rather than by acting directly on its activity.
Intracellular effectors downstream of Eph-B have been described in several contexts (Kania and Klein, 2016) , however the mechanisms underlying their effect on transcriptional
programs have yet to be fully understood. One of the main candidate to fulfill the mediator role is AKT which acts as a hub controlling the activity of a plethora of transcription factors (Manning and Cantley, 2007) . Upon eB1-Fc treatment, AKT is phosphorylated with similar kinetics to those observed for Eph-B ( Figure S1E ) indicating that AKT is an effector of Eph-B forward signaling in NSC. To test this, we incubated NSC with AKT VIII or LY294002, two AKT inhibitors which efficiently inhibited AKT phosphorylation ( Figure 1E ). Interestingly, AKT inhibition prevented the decrease in DHFR protein levels 72h post-eB1-Fc treatment ( Figure 1E ).
Thus, our data indicate that Eph-B forward signaling leads to a decrease in DHFR protein level via AKT.
Eph-B Forward signaling impairs NSC self-renewal and promotes their differentiation
To test whether Eph signaling and DHFR inhibition are relevant for NSC maintenance, we tested the capacity of these cells to form secondary spheres which is an indicator of self-renewal. We treated NSC with a single dose of eB1-Fc with or without folinic acid (FNA) which replenishes the THF pools depleted by DHFR inhibition (Ortiz et al., 2000; van Ede et al., 2001 ). eB1-Fc treatment led to a decreased number of secondary spheres which was rescued by FNA supplementation (Figure 2A) . Similarly, inhibition of DHFR by MTX treatment also led to a decrease in the number of secondary spheres which was rescued by FNA ( Figure S2A ). These results indicate that inhibition of DHFR leads to a decrease in the self-renewing potential of NSC.
This decrease in self-renewing potential could be due to a decrease in the rate of proliferation or apoptosis. Thus, we tested whether these two parameters were altered following eB1-Fc treatment. Activation of Eph-B forward signaling did not lead to a significant modification in cell number until 16 days (d) post-treatment ( Figure 2B ) and it had no effect on the mitotic index or apoptosis at 7d ( Figure 2C -F). These results suggest that decreased proliferation or increased apoptosis are not the driving factors leading to the change in selfrenewing potential observed upon eB1-Fc treatment.
Next, we hypothesized that the decrease in the self-renewing potential induced by Eph-B forward signaling was due to enhanced differentiation. In self-renewing culture conditions neurospheres are heterogeneous due to NSC spontaneous differentiation in neurospheres. In these conditions, we assessed whether activation of Eph signaling is sufficient to promote differentiation. We performed FACS analyses with markers of progenitor cells (SOX2) and differentiated cells (TUJ1, GFAP, O4). While these analyses of eB1-Fc treated NSC showed no significant differences 72h post-treatment ( Figure 2G ), we observed an expansion of the fraction of differentiated cells at the expense of progenitor cells 7d post-treatment ( Figure 2H ). In addition, while FNA supplementation alone had no effect on NSC differentiation, it was sufficient to rescue the loss of progenitor cells following eB1-Fc treatment ( Figure 2H ).
Immunofluorescence (IF) analysis confirmed the decrease in progenitor cells (SOX2+) and the increase in neurons (TUJ1+), oligodendrocytes (O4+) and astrocytes (GFAP+) ( Figure S2C ).
Importantly, inhibition of DHFR by MTX resulted in a similar decrease in the progenitor fraction and an increase in the differentiated fraction that could be rescued by FNA supplementation (Figure S2B and D) . These results indicate that Eph-B forward signaling decreased the progenitor pool by altering the 1C folate pathway and promoting differentiation at the expense of selfrenewal.
Inhibition of DHFR via Eph-B forward signaling alters epigenetic marks in NSC
One carbon folate pathway has been linked to altered Histone3 methylation (Garcia et al., 2016; Mentch et al., 2015; Shyh-Chang et al., 2013b) . We thus analyzed methylation on Histone3, which is known to be required for the maintenance of defined cellular states (Benayoun et al., 2014; Mohamed Ariff et al., 2012) , in response to eB1-Fc or MTX treatment as a control. At 72h and prior to any detectable differentiation ( Figure 2G ), eB1-Fc treatments led to a significant decrease in the H3K4me3 levels and to lesser extents both levels of H3K9me2 and H3K27me3
( Figure 3A ). Interestingly, H3K4me3 decrease correlated temporally with the decrease in DHFR activity as no significant change of this mark was observed prior to 72h post-eB1-Fc treatment ( Figure S3A ). To ascertain that the decrease in H3K4me3 was due to altered 1C folate metabolism, we repeated the experiment in presence of FNA. Supplementation with FNA rescued the decreased H3K4me3 in both eB1-Fc and MTX treatments ( Figure 3B ). Moreover, inhibition of AKT prevented the decrease in H3K4me3 ( Figure S3B ) consistent with this mark being downstream of DHFR inhibition.
It was recently shown that perturbation of mitochondrial function impacts NSC selfrenewal in the developing neocortex (Khacho et al., 2017) . In order to assert that the epigenetic changes observed above were the cause and not the consequence of NSC differentiation, we perturbed mitochondrial electron transport chain using Oligomycin, an ATP synthase inhibitor (Liu and Schubert, 2009) . As expected, Oligomycin-treatment decreased the NSC capacity to form secondary spheres ( Figure S3C ). FACS and IF analysis revealed an increase in the differentiated fraction and a decrease in the progenitor fraction following Oligomycin treatment ( Figure S3D and E). Importantly, while Oligomycin treatment impaired NSC self-renewal in a manner similar to eB1-Fc treatment, no change in total H3K4me3 levels was detected ( Figure   3C ). Thus, the decrease in H3K4me3 observed following eB1-Fc treatment is not an indirect consequence of differentiation.
H3K4me3 is important for maintaining euchromatin and is generally associated with promoters of actively transcribed genes (Benayoun et al., 2014 Figure 3D ). Consistent with our previous data, DHFR inhibition by MTX also led to a decrease in H3K4me3 at promoter regions of progenitor-specific genes ( Figure S3F ). In contrast, the level of H3K4me3 were either not changed or increased at the promoter of differentiation-related genes in response to eB1-Fc or Oligomycin treatment ( Figure 3E ), suggesting that this increase was associated with induced differentiation.
Importantly, the changes of H3K4me3 at promoters of progenitor and differentiation specific genes in response to eB1-Fc treatment correlated with changes in mRNA levels of these genes ( Figure 3F ), consistent with the fact that enrichment of H3K4me3 is observed at actively transcribed promoters. These results indicate that DHFR inhibition leads to decreased H3K4 trimethylation which differentially affects promoters of progenitor vs. differentiation-related genes.
Together, these data show that while Eph-B forward signaling, MTX and Oligomycin treatment lead to a reduction in the progenitor pool, they do so by different mechanisms. This strongly supports the notion that Eph-B forward signaling controls NSC self-renewal through 1C
folate mediated modification of epigenetic marks.
Long term inheritance of the epigenetic marks and differentiation program induced by DHFR inhibition
Changes in histone methylation are generally associated with stable cell fate decisions (Greer and Shi, 2012) . To investigate the stability of the epigenetic changes observed upon eB1-Fc treatment, we analyzed H3K4me3 levels at the promoters of progenitor and differentiationspecific genes after dissociation of the treated NSC (first generation) and culture without treatment (second generation) ( Figure 4A ). Under these conditions, 3 out of 4 selected promoter 1 0 regions for progenitor-specific genes exhibited decreased H3K4me3 in progeny of cells that had been previously exposed to eB1-Fc treatment ( Figure 4B ) despite the fact that DHFR activity was no longer inhibited ( Figure 4C ). As expected, initial Oligomycin treatment, had no effect on the level of H3K4me3 at the promoter of either Sox2 or Nes in NSC progeny ( Figure 4B) . Similarly, the significant increase in H3K4me3 at the promoter of Dcx in response to eB1-Fc treatment was maintained in second generation NSC ( Figure 4D ). These results indicate that the changes in H3K4me3 at specific promoter regions are inherited from the initial treatment.
The inheritance of the changes in H3K4me3 following eB1-Fc initial treatment suggested that the pro-differentiation transcriptional program was also inherited by the progeny. To confirm this hypothesis, we tested the stemness as well as the different cell populations within the second generation neurospheres 14 days post-eB1-Fc treatment. Similar to the first generation, the selfrenewal capacity of the secondary NSC was also lower following the initial treatment with eB1-Fc ( Figure 5A ). This decrease was not a consequence of the overall decrease of progenitors following the initial treatment since Oligomycin treatment that induced a high decrease in the progenitor pool in the first generation ( Figure S3D ), had no detectable effect on the second generation ( Figure 5B ). Consistently, this decrease in stemness was also observed by FACS and IF analysis where the decrease in the progenitor fraction correlated with an increase in the fraction of second generation differentiated cells ( Figure 5C and S4A) but not with Oligomycin treatment ( Figure 5D and S4B). Finally, FNA supplementation of first generation NSC rescued the phenotype observed following eB1-Fc treatment at day 14 ( Figure 5C and S4A). These results reveal the co-inheritance of changes in H3K4me3 epigenetic marks and changes in progenitor vs.
differentiated fraction following eB1-Fc stimulation. Taken together, these results show that Eph-B forward signaling triggers long term epigenetic changes promoting differentiation and suppressing self-renewal.
Eph-B forward signaling induces NSC differentiation via the folate pathway in the developing neocortex
Next, we thought to assess whether regulation of DHFR expression by Eph-B forward signaling was relevant to NSC self-renewal vs. differentiation in vivo. First we mined a recently published single-cell RNA-sequencing (RNA-seq) dataset of mouse embryonic cortical progenitors and their progeny (Okamoto et al., 2016) . These bioinformatics analyses revealed a correlation between decreased DHFR expression and neuronal differentiation ( Figure S5A ). This is consistent with previously published global analysis of gene expression in neural progenitors revealing that the folate pathway is upregulated in NSC compared to their differentiated progeny (Karsten et al., 2003) . Furthermore, analysis of DHFR expression within the apical progenitor population revealed an inverse correlation with Eph-B2 expression. Indeed, cells with high EphB2 expression exhibited the lowest DHFR expression ( Figure S5B ) strengthening the link between Eph-B forward signaling and DHFR. Next, in order to confirm this link genetically, we generated Efnb1/Efnb2 double knock out embryos (dKO) and analyzed them at E13.5, a developmental stage at which the neocortex is mostly composed of neural progenitors. Westernblot analyses of neocortex tissue show that as expected, phosphorylation of Eph-B receptors is decreased in dKO embryos indicating that Eph-B signaling is turned off ( Figure 6A ).
Importantly, this inactivation of Eph-B signaling in dKO embryos correlated with an increase in DHFR and in H3K4me3 levels compared to wild type embryos ( Figure 6B ). Finally, we detected an increase in both SOX2 and Nestin in dKO embryos strengthening the link between DHFR/H3K4me3 levels and the expression of these progenitor-related genes ( Figure 6B ). These data clearly demonstrate the molecular link between Eph-B forward signaling, DHFR expression and levels of H3K4me3 in vivo.
Next, to validate the role of the Eph-B forward signaling/folate axis in the control of NSC maintenance and differentiation in vivo, we injected eB1-Fc or eB1-Fc with FNA into the ventricles of E13.5 embryos in utero and analyzed the progenitor and neuronal fractions at E16.5. be due to the fact that all of the in vitro analyses were performed in culture conditions that favor self-renewal whereas NSC in the developing neocortex are exposed to differentiative cues.
Interestingly, our in vitro data shows that once modified, the epigenetic landscape and the prodifferentiative state of NSC is maintained in the long term, suggesting that signaling events occurring early in the neocortex developmental sequence may have consequences at later time.
The 1C pathway has two major branches, the Methionine and DNA synthesis branches that act on methylation reaction and cellular proliferation respectively. Since no apoptosis and cellular proliferation defects were observed, our results indicate that activation of Eph signaling 
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• KEY RESOURCES (E) NSC were treated with either AKT VIII or LY294002 inhibitors for 30min and 72h then analyzed by western blot with the indicated antibodies.
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Statistical analysis was performed using Mann Whitney test (B) and one-way ANOVA test followed by the Bonferroni method (D). Data are reported as mean ± SEM (*P < 0.05; **P < 0.01; *** P<0;005). Statistical analysis was performed using paired t-test (D, E) and ratio paired t-test (F). Data are reported as mean ± SEM (*P < 0.05; **P < 0.01). (D) DHFR activity was measured in NSC treated as in (A).
Statistical analysis was performed using paired t-test (B, D) and Mann Whitney test (C). Data are
reported as mean ± SEM (*P < 0.05; **P < 0.01). Statistical analysis was performed using one-way ANOVA test followed by the Bonferroni method (C, E). Data are reported as mean ± SEM (*P < 0.05, **P < 0.01). 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
Wild type mice kept in a 129S4/C57Bl6J mixed background were bred in the animal facility. Efnb1 loxlox , Efnb2 loxlox and Nestin-Cre mouse lines have been described previously (Davy et al., 2004; Grunwald et al., 2004; Tronche et al., 1999 
Culture of NPCs and maintenance
Cultures of primary NPCs were obtained as described previously (Chojnacki and Weiss, 2008) . Briefly, embryonic day 14.5 (E14.5) cortices were dissected mechanically in phosphate buffered saline solution (PBS) (Cat#D1408, Sigma). The single-cell suspension was collected, rinsed with DMEM/F12 (Cat#1130-032, Invitrogen), and cultured with growing medium (DMEM/F12 medium containing 0.6% glucose (Cat#UG3050, Euromedex), 5 mM HEPES (Cat#H3375, Sigma), 1 mM putrescine (Cat#P5780, Sigma), 5 ng/ml basic fibroblast growth factor 2 [FGF-2] ( Cat#F029, Sigma), 20 ng/ml epidermal growth factor [EGF] (Cat#E9644, Sigma), 10 ng/ml insulin-transferrin-sodium selenite supplement (Cat#I1844-1VL, Sigma) and 2% B27 supplement (Cat#17504-044,Invitrogen)) in a 5% CO 2 incubator at 37°C. Several different primary cultures were obtained and kept in culture for no more than 5 passages. Fresh medium was added every 2-3 days to the culture and passage was realized once a week using Accutase® (Cat#A6964, Sigma).
METHODS DETAILS
Stimulation of Eph Forward Signaling
Prior to stimulation, neurospheres were dissociated with Accutase ® (Cat#A6964, Sigma), and aliquots of 10 5 cells were placed in growing medium then stimulated with 1 μ g/ml eB1-Fc (Cat#473-EB, R&S Systems) preclustered with 0.1 μ g/ml anti-human IgG (Cat#G-101-C-ABS, R&D Systems). Total RNA was isolated 6h, 72h post-stimulation and processed for qRT-PCR. Alternatively, cells were stimulated for 30min, 6h, 24h and 72h and lysed in protein lysis buffer for Western blot analysis. protease inhibitors (Cat#11836170001, Roche) and lysed mechanically using glass beads (Cat#G8772, Sigma). Lysates were precleared by centrifugation at 13,000 rpm for 10 min. The supernatant was used immediately for enzyme assay after the determination of protein concentration.
Chromatin Immunoprecipitation Protocol
NPCs were treated as described above and cultured for 72h. Cells were fixed with 1% formaldehyde (Cat#15710, Fisher Scientific) for 15 min at room temperature, with occasional swirling. Glycine (Cat#G7126, Sigma) was added to a final concentration of 0.125 M and the incubation was continued for an additional 5 min. Cells were collected and washed with ice-cold PBS (Cat#D1408, Sigma) three times and resuspended in cell lysis buffer (5 mM Pipes [pH 8] (Cat#P6757, Sigma), 85 mM KCl (Cat#P017-A, Euromedex), 0.5% NP-40 (Cat#N6507, Sigma), Protease inhibitors (Cat#11836170001, Roche). Cells were centrifuged at 4000 rpm for 10 min at 4°C. Pellets were then resuspended in Nuclei lysis buffer (50 mM Tris-HCl [pH 8] (Cat#EU0011, Euromedex), 10 mM EDTA, 1% SDS). The cells were disrupted by sonication (30 cycles, 30 secs on, 60 secs off) with Biorupter® Sonicator (Cat#B01020001, Diagenode). The chromatin solution was clarified by centrifugation at 15,000 g at 4°C for 10 min. The average DNA fragment size was 250 pb. The chromatin solution was diluted with IP dilution buffer (16.7 mM Tris-HCl [pH 8], 1.2 mM EDTA (Cat#EU0007, Euromedex), 1.1 mM Triton X-100 (Cat#T9284, Sigma), 0.01% SDS (Cat#EU0660, Euromedex) and 167 mM NaCl (Cat#1112-A, Euromedex) and pre-cleared with pre-blocked beads (protein G Sepharose (Cat#3296, Sigma)/protein A agarose (Cat#6526, BioVision) (50/50) overnight with PBS/0.5% BSA (Cat#04100811C, Euromedex), 10mg/ml yeast tRNA (Cat#AM7119, ThermoFisher) beads for 1h at 4°C. The precleared diluted chromatin sample was incubated with 3 μ g of anti-H3K4me3 (Cat#ab8580, Abcam) overnight at 4°C. Preblocked beads were added for an additional 4h. The beads were washed twice with the dialysis buffer (2 mM EDTA, 50 mM Tris-HCl [pH 8] and 0.2% Nlauroylsarcosine (Cat#L5777, Sigma), 4 times with wash buffer (100 mM Tris-HCl [pH 8], 500 mM LiCl (Cat#L4408, Sigma), 1% NP-40 and 1% sodium Deoxycholate (Cat#D6750, Sigma) and twice with TE buffer (10 mM Tris-HCl [pH 8] and 1 mM EDTA). The immunoprecipitated material was eluted from the beads by heating for 15 min at 65°C in 1% SDS, 50 mM NaHCO3 (Cat#71631, Sigma). 0.2 M NaCl (Cat#1112-A, Euromedex) and 10μg/ml RNAse A (Cat#EN0531, ThermoFisher) were added before incubating for 2h at 64°C to reverse the crosslinks. Samples were then incubated with 1.5 μ g/ml Proteinase K (Cat#P6556, Sigma), 40 mM Tris-HCl [pH 8], 10 mM EDTA at 45°C for 1h. The samples were then extracted with phenol chloroform isoamyl alcohol (Cat#0038.2, Carl ROTH) followed by ethanol (Cat#20821.330, VWR chemicals) precipitation in the presence of glycogen (Cat#R0561, ThermoFisher), and resuspended in DNAse-free water (Cat#W4502, Sigma). The resulting precipitated DNA was amplified and analyzed by qRT-PCR as described above.
STATISTICAL ANALYSIS
For experiments involving a single pair of conditions, statistical significance between the two sets of data were analyzed with a Mann-Whitney and Wilcoxon test with Prism5 (GraphPad software). For datasets containing more than two samples, one-way analysis of variance with either Bonferroni or Fisher's LSD multiple comparison post-test was used to determine adjusted p-values. Sample sizes of sufficient power were chosen on the basis of similar published research and were confirmed statistically by appropriate tests. Each experiment was performed at least three times, and 100-500 cells were counted for each condition of each experiment. Statistically significant differences are reported at P < 0.05, P < 0.01, P < 0.001.
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